Clinical Trials
Trodelvy Breast Cancer Drug Makes A Spectacular Comeback
After unimpressive evidence on tumour progression, many Gilead Sciences investors have stopped believing in Trodelvy in HR-positive, HER2-negative breast cancer. But now that the...
News
3 Unusual Foods and Drinks You Should Try at Least Once
If you are a total foodie and you’re looking for some inspiration, you’ve come to the right place. Food trends made for the Gram...
News
5 Ways AI Can Improve The Pharma Industry
Pharmaceuticals are a vital part of the healthcare industry. They help improve the quality of drugs and services they provide, as well as discover...
Drug Research
Introduction of Anti-Evolocumab Antibodies From Bio-Rad
A group of type 1 antibodies recently made available by Bio-Rad Laboratories are intended to prevent the drug evolcumab from attaching to its target,...
News
For $1.1 Billion, Novo Nordisk To Buy Forma Therapeutics
On September 1, 2022, Novo Nordisk and Forma Therapeutics revealed that Novo Nordisk would buy Forma Therapeutics for for $1.1 billion. With the purchase...
Drug Research
Merck Assesses 5 Years of Keytruda Lung Cancer Research
By demonstrating a massive survival benefit, Keytruda's Keynote-189 study precipitated a turning point in the development of lung cancer medications. Merck & Co. is...
Drug Research
Modus Therapeutics Enrols First Patient To Explore Sevuparin
The treatment for paediatric patients with severe malaria is being evaluated through research.
The first patient has been enrolled in the SEVUSMART study, according to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read